Patterns of Vitamin D Testing and Supplementation for Children with Inflammatory Bowel Disease in Australasia

Overview

Journal JGH Open

Specialty Gastroenterology

Date 2024 Mar 6

PMID 38444634

Authors

Angharad Vernon-Roberts

Andrew S Day

Affiliations

Soon will be listed here.

Abstract

Background And Aim: For children with inflammatory bowel disease (IBD), optimal levels of vitamin D are ascribed anti-inflammatory and essential immune system roles that are associated with reduced disease activity, lower postoperative recurrence, and higher quality of life. International guidelines for vitamin D testing and supplementation provide inconsistent recommendations. The aim of this study was to survey Australasian pediatric gastroenterologists to ascertain current practices of vitamin D testing and supplementation for children with IBD.

Methods: Members of the Australian Society of Pediatric Gastroenterology, Hepatology and Nutrition were invited to complete an online survey. Respondents were asked to provide information on frequency of vitamin D testing and supplementation, adherence, and benefits of vitamin D to children with IBD.

Results: Thirty-two (54%) pediatric gastroenterologists completed the survey: 27 (84%) from Australia and 5 (16%) from New Zealand. The majority (90%) tested vitamin D levels at diagnosis and follow up, although testing frequency varied (1-3 times/year) and only 8 (28%) tested seasonally. While 28 (88%) recommended supplementation based on serum levels, inconsistent cutoff values were used. Most respondents ( = 27) recommended Stoss (single dose) or vitamin D3 (daily for 8-12 weeks). The majority (84%) rated the overall benefit of optimal vitamin D levels at ≥6/10, although fewer (54%) rated the benefit to disease activity at ≥6/10.

Conclusions: The results indicate that standardized guidelines for vitamin D testing and supplementation for clinicians caring for children with IBD throughout Australasia are required. Consensus statements may optimize the care of children with IBD in this diverse geographical region.

References

Guzman-Prado Y, Samson O, Segal J, Limdi J, Hayee B . Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2020; 26(12):1819-1830. DOI: 10.1093/ibd/izaa087. View

Ruemmele F, Veres G, Kolho K, Griffiths A, Levine A, Escher J . Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis. 2014; 8(10):1179-207. DOI: 10.1016/j.crohns.2014.04.005. View

Meeker S, Seamons A, Maggio-Price L, Paik J . Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol. 2016; 22(3):933-48. PMC: 4716046. DOI: 10.3748/wjg.v22.i3.933. View

Priemel M, von Domarus C, Klatte T, Kessler S, Schlie J, Meier S . Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2009; 25(2):305-12. DOI: 10.1359/jbmr.090728. View

Pappa H, Langereis E, Grand R, Gordon C . Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011; 53(4):361-4. PMC: 3188377. DOI: 10.1097/MPG.0b013e3182250b3e. View

Holmes E, Rodney Harris R, Lucas R . Low Sun Exposure and Vitamin D Deficiency as Risk Factors for Inflammatory Bowel Disease, With a Focus on Childhood Onset. Photochem Photobiol. 2018; 95(1):105-118. DOI: 10.1111/php.13007. View

Lopez R, Appleton L, Gearry R, Day A . Rising Incidence of Paediatric Inflammatory Bowel Disease in Canterbury, New Zealand, 1996-2015. J Pediatr Gastroenterol Nutr. 2017; 66(2):e45-e50. DOI: 10.1097/MPG.0000000000001688. View

Nielsen O, Rejnmark L, Moss A . Role of Vitamin D in the Natural History of Inflammatory Bowel Disease. J Crohns Colitis. 2018; 12(6):742-752. DOI: 10.1093/ecco-jcc/jjy025. View

Busingye D, Pollack A, Chidwick K . Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study. PLoS One. 2021; 16(5):e0252458. PMC: 8158877. DOI: 10.1371/journal.pone.0252458. View

10.

Rigterink T, Appleton L, Day A . Vitamin D therapy in children with inflammatory bowel disease: A systematic review. World J Clin Pediatr. 2019; 8(1):1-14. PMC: 6347665. DOI: 10.5409/wjcp.v8.i1.1. View

11.

Pappa H, Mitchell P, Jiang H, Kassiff S, Filip-Dhima R, DiFabio D . Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens. J Clin Endocrinol Metab. 2012; 97(6):2134-42. PMC: 3387426. DOI: 10.1210/jc.2011-3182. View

12.

Kim S, Kang Y, Park S, Koh H, Kim S . Association of Vitamin D with Inflammatory Bowel Disease Activity in Pediatric Patients. J Korean Med Sci. 2019; 34(32):e204. PMC: 6698452. DOI: 10.3346/jkms.2019.34.e204. View

13.

Lopez R, Evans H, Appleton L, Bishop J, Chin S, Mouat S . Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study. Inflamm Bowel Dis. 2017; 23(8):1418-1424. DOI: 10.1097/MIB.0000000000001138. View

14.

van Rheenen P, Aloi M, Assa A, Bronsky J, Escher J, Fagerberg U . The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. 2020; . DOI: 10.1093/ecco-jcc/jjaa161. View

15.

Conklin L, Oliva-Hemker M . Nutritional considerations in pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010; 4(3):305-17. DOI: 10.1586/egh.10.23. View

16.

Sohouli M, Farahmand F, Alimadadi H, Rahmani P, Motamed F, Magalhaes E . Vitamin D therapy in pediatric patients with inflammatory bowel disease: a systematic review and meta-analysis. World J Pediatr. 2022; 19(1):48-57. DOI: 10.1007/s12519-022-00605-6. View

17.

Nowson C, McGrath J, Ebeling P, Haikerwal A, Daly R, Sanders K . Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust. 2012; 196(11):686-7. DOI: 10.5694/mja11.10301. View

18.

Turner D, Ruemmele F, Orlanski-Meyer E, Griffiths A, de Carpi J, Bronsky J . Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018; 67(2):257-291. DOI: 10.1097/MPG.0000000000002035. View

19.

Pappa H, Grand R, Gordon C . Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006; 12(12):1162-74. DOI: 10.1097/01.mib.0000236929.74040.b0. View

20.

Sykora J, Pomahacova R, Kreslova M, Cvalinova D, Stych P, Schwarz J . Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol. 2018; 24(25):2741-2763. PMC: 6034144. DOI: 10.3748/wjg.v24.i25.2741. View